Unveiling the role of network and systems biology in drug discovery

被引:225
作者
Pujol, Albert [1 ,2 ,4 ]
Mosca, Roberto [1 ,4 ]
Farres, Judith [2 ]
Aloy, Patrick [1 ,3 ,4 ]
机构
[1] Inst Res Biomed, Barcelona 08028, Spain
[2] Anax Biotech, Barcelona 08008, Spain
[3] ICREA, Barcelona 08010, Spain
[4] Barcelona Supercomp Ctr, Barcelona 08028, Spain
关键词
SPECTROMETRY-BASED PROTEOMICS; PROTEIN-PROTEIN INTERACTIONS; MAGIC BULLETS; COMBINATION; INNOVATION; DISORDERS; ALIGNMENT; THERAPY; TARGETS; TRAITS;
D O I
10.1016/j.tips.2009.11.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Network and systems biology offer a novel way of approaching drug discovery by developing models that consider the global physiological environment of protein targets, and the effects of modifying them, without losing the key molecular details. Here we review some recent advances in network and systems biology applied to human health, and discuss how they can have a big impact on some of the most interesting areas of drug discovery. In particular, we claim that network biology will play a central part in the development of novel polypharmacology strategies to fight complex multifactorial diseases, where efficacious therapies will need to center on altering entire pathways rather than single proteins. We briefly present new developments in the two areas where we believe network and system biology strategies are more likely to have an immediate contribution: predictive toxicology and drug repurposing.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 96 条
[41]   Biological robustness [J].
Kitano, H .
NATURE REVIEWS GENETICS, 2004, 5 (11) :826-837
[42]   Innovation - A robustness-based approach to systems-oriented drug design [J].
Kitano, Hiroaki .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (03) :202-210
[43]   International alliances for quantitative modeling in systems biology [J].
Kitano, Hiroaki .
MOLECULAR SYSTEMS BIOLOGY, 2005, 1 (1) :2005.0007
[44]   Hypergraphs and Cellular Networks [J].
Klamt, Steffen ;
Haus, Utz-Uwe ;
Theis, Fabian .
PLOS COMPUTATIONAL BIOLOGY, 2009, 5 (05)
[45]   Bioinformatics analysis of mass spectrometry-based proteomics data sets [J].
Kumar, Chanchal ;
Mann, Matthias .
FEBS LETTERS, 2009, 583 (11) :1703-1712
[46]   Relationships between probabilistic Boolean networks and dynamic Bayesian networks as models of gene regulatory networks [J].
Lähdesmäki, H ;
Hautaniemi, S ;
Shmulevich, I ;
Yli-Harja, O .
SIGNAL PROCESSING, 2006, 86 (04) :814-834
[47]   Initial sequencing and analysis of the human genome [J].
Lander, ES ;
Int Human Genome Sequencing Consortium ;
Linton, LM ;
Birren, B ;
Nusbaum, C ;
Zody, MC ;
Baldwin, J ;
Devon, K ;
Dewar, K ;
Doyle, M ;
FitzHugh, W ;
Funke, R ;
Gage, D ;
Harris, K ;
Heaford, A ;
Howland, J ;
Kann, L ;
Lehoczky, J ;
LeVine, R ;
McEwan, P ;
McKernan, K ;
Meldrim, J ;
Mesirov, JP ;
Miranda, C ;
Morris, W ;
Naylor, J ;
Raymond, C ;
Rosetti, M ;
Santos, R ;
Sheridan, A ;
Sougnez, C ;
Stange-Thomann, N ;
Stojanovic, N ;
Subramanian, A ;
Wyman, D ;
Rogers, J ;
Sulston, J ;
Ainscough, R ;
Beck, S ;
Bentley, D ;
Burton, J ;
Clee, C ;
Carter, N ;
Coulson, A ;
Deadman, R ;
Deloukas, P ;
Dunham, A ;
Dunham, I ;
Durbin, R ;
French, L .
NATURE, 2001, 409 (6822) :860-921
[48]   Reactions and interactions of some commonly used systemic drugs in dermatology [J].
Le Cleach, L ;
Bocquet, H ;
Roujeau, JC .
DERMATOLOGIC CLINICS, 1998, 16 (02) :421-+
[49]   The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action [J].
Lee, Margaret S. ;
Johansen, Lisa ;
Zhang, Yanzhen ;
Wilson, Amy ;
Keegan, Mitchell ;
Avery, William ;
Elliott, Peter ;
Borisy, Alexis A. ;
Keith, Curtis T. .
CANCER RESEARCH, 2007, 67 (23) :11359-11367
[50]   Combination chemical genetics [J].
Lehar, Joseph ;
Stockwell, Brent R. ;
Giaever, Guri ;
Nislow, Corey .
NATURE CHEMICAL BIOLOGY, 2008, 4 (11) :674-681